Most Psychiatry Experts are Paid Shills for Big Pharma

When The Media Says "Experts" They Mean Paid Corporate Shills (Part 41)

An assessment of financial conflicts of interest, published in the British Medical Journal, found that 60% of U.S. physicians who contributed to DSM-5-TR manual as either panel or task force members received a cumulative $14.2 million in payments from the pharma industry. This is not the first time that psychiatrists involved in writing the Diagnostic Manual for their profession were found to be on the dole of an industry that stands to make windfalls from expanding the scope of mental disorders. An assessment of the DSM-5 task force, which published their manual in 2013, found that nearly 70% of task force members had financial ties to industry. For particular DSM-5 panels, 67% of panel members for mood disorders, 83% of panel members for psychotic disorders and 100% of panel members for sleep/wake disorders had direct financial ties to the Pharma conglomerates that manufacture drugs prescribed to treat the respective cluster of disorders the panel members established criteria for. Before that, 57% of the earlier DSM-4 task force members, who published their manual in 1994, also had financial ties to Big Pharma.